Erik Herman
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Biophysics top 5%
- Electron Spin Resonance Studies
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 18
- Cardiac electrophysiology and arrhythmias 10
-
- Ion channel regulation and function 6
- Cancer therapeutics and mechanisms 5
- Co-authors
- V J Ferrans (18 shared papers)V.S. Waravdekar (8 shared papers)Brian B. Hasinoff (3 shared papers)K. Hellmann (2 shared papers)P. Schein (3 shared papers)John F. Van Vleet (2 shared papers)A Rahman (1 shared paper)Jun Zhang (2 shared papers)
- Journals
- Toxicology and Applied Pharmacology (8 papers)Pharmacology (6 papers)Experimental Biology and Medicine (5 papers)Cancer Chemotherapy and Pharmacology (3 papers)Inflammation Research (2 papers)
- Partner nations
- United StatesCzechiaThailand
In The Last Decade
Erik Herman
56 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 101
- Cardiology and Cardiovascular Medicine 754
- Biophysics 109
- Oncology 443
- Psychiatry and Mental health 238
- Dermatology 91
Countries citing papers authored by Erik Herman
This map shows the geographic impact of Erik Herman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Herman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Herman more than expected).
Fields of papers citing papers by Erik Herman
This network shows the impact of papers produced by Erik Herman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Herman. The network helps show where Erik Herman may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Herman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation. | 1983 | 143 |
| 2 | 1998 | 130 | |
| 3 | Cervical papillomavirus infection and intraepithelial neoplasia: a study of male sexual partners. | 1984 | 102 |
| 4 | Comparison of the effectiveness of (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles. | 1985 | 101 |
| 5 | Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity. | 1998 | 90 |
| 6 | 2007 | 88 | |
| 7 | 2000 | 69 | |
| 8 | Pathogenesis and prevention of doxorubicin cardiomyopathy. | 1997 | 56 |
| 9 | Effect of pretreatment with ICRF-187 on the total cumulative dose of doxorubicin tolerated by beagle dogs. | 1988 | 49 |
| 10 | 1972 | 48 | |
| 11 | 1994 | 48 | |
| 12 | 2007 | 46 | |
| 13 | Reduction of daunorubicin lethality and myocardial cellular alterations by pretreatment with ICRF-187 in Syrian golden hamsters. | 1979 | 44 |
| 14 | 1974 | 39 | |
| 15 | Dendritic cells in the hearts of spontaneously hypertensive rats treated with doxorubicin with or without ICRF-187. | 1993 | 35 |
| 16 | The possible relationship between metabolism and cardiac toxicity of duanomycin and related compounds. | 1971 | 30 |
| 17 | 1995 | 28 | |
| 18 | 2020 | 27 | |
| 19 | 1993 | 25 | |
| 20 | 1997 | 23 |
About Erik Herman
Erik Herman is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Psychiatry and Mental health, Pharmacology and Oncology, having authored 66 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (18 papers), Cardiac electrophysiology and arrhythmias (10 papers), Cancer Treatment and Pharmacology (6 papers), Ion channel regulation and function (6 papers), Electron Spin Resonance Studies (5 papers), Cancer therapeutics and mechanisms (5 papers), Synthesis and Biological Evaluation (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (754 citations), Biophysics (109 citations), Oncology (443 citations), Psychiatry and Mental health (238 citations) and Dermatology (91 citations). Erik Herman has collaborated with scholars based in United States, Czechia and Thailand. Frequent co-authors include V J Ferrans, V.S. Waravdekar, Brian B. Hasinoff, K. Hellmann, P. Schein, John F. Van Vleet, A Rahman, Jun Zhang, Charles E. Myers and Douglas P. Chadwick. Their work appears in journals such as Toxicology and Applied Pharmacology, Pharmacology, Experimental Biology and Medicine, Cancer Chemotherapy and Pharmacology and Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.